Morgellons is a skin condition characterized by slow-healing lesions containing unusual filaments, fibers, or thread-like structures that appear embedded in, lying under, or projecting from the skin. People with the condition typically report intense crawling, stinging, or biting sensations, along with chronic fatigue and cognitive difficulties. It remains one of the most contested conditions in medicine, with mainstream dermatology and a growing group of infectious disease researchers offering fundamentally different explanations for what causes it.
How Morgellons Looks and Feels
The hallmark feature is the appearance of multicolored filaments in skin lesions. These fibers can be white, black, blue, or red, and they may be visible to the naked eye or only under magnification. The lesions themselves tend to heal slowly and can appear as open sores, papules, or ulcerative wounds. Many patients also develop calluses, dry or flaking skin, hair loss, unusual nail growth, and significant scarring with changes in skin pigmentation.
Beyond what’s visible on the skin, the subjective experience is often described as something crawling on or under the skin, combined with stinging or biting. In one clinical study of 122 patients with confirmed subcutaneous fibers, 62% reported new-onset anxiety or panic attacks, and about 29% were being treated for depression. The psychological burden is substantial, partly because the symptoms are distressing on their own and partly because many patients struggle to get their condition taken seriously.
Two Competing Explanations
The medical community is split on what Morgellons actually is, and the divide runs deep.
The mainstream view, held by most dermatologists and supported by a major investigation from the Centers for Disease Control and Prevention, is that Morgellons is a form of delusional infestation. The CDC studied a group of patients and concluded that most materials collected from their skin were composed of cellulose, likely cotton from clothing or bandages. No parasites, mycobacteria, or common infectious agents were found. The study suggested that fibers in the sores could be explained by repeated scratching and contamination from fabric rather than fibers growing out of the skin itself. Under this framework, Morgellons is classified alongside other conditions where a person holds a fixed belief that organisms are infesting their body, despite no clinical evidence of infection.
A smaller but persistent group of researchers, many specializing in tick-borne diseases, argues that Morgellons is a genuine skin disease linked to infection. Histological studies from this camp have found that the filaments are not textile fibers at all but are biofilaments of human cellular origin, predominantly composed of collagen and keratin. These filaments appear to originate from deeper layers of the skin, including the upper dermis and the root sheath of hair follicles. Electron microscopy has shown that blue fibers, often cited as evidence of textile contamination, are actually microscopic hairs containing melanin pigment, consistent with biological structures rather than clothing threads.
The Lyme Disease Connection
Researchers who view Morgellons as a physical illness have focused heavily on its overlap with Lyme disease. A study of 25 patients used multiple detection methods to identify Borrelia spirochetes, the bacteria responsible for Lyme disease, in skin tissue from Morgellons lesions. The researchers reported a high success rate in detecting spirochetal DNA, and many patients showed blood test reactivity to Borrelia antigens. Some patients also tested positive for other tick-borne infections, including Babesia, Anaplasma, Ehrlichia, and Bartonella.
This group also points to an animal parallel. Bovine digital dermatitis, a common condition in dairy cattle, produces strikingly similar skin lesions with proliferative keratin filaments. In cattle, the disease is caused by Treponema spirochetes, close relatives of the bacteria that cause Lyme disease. Researchers have proposed that if spirochetes can cause filament-producing skin disease in cattle, a similar mechanism could explain what happens in Morgellons patients. The comparison remains controversial, but it offers a biological model that the delusional infestation framework does not.
How It Gets Diagnosed
There is no universally accepted diagnostic test for Morgellons. Proposed clinical criteria center on one primary feature: multicolored filaments embedded within or protruding from the skin, visible under magnification. Secondary features that support the diagnosis include slow-healing ulcerative lesions, burning or stinging sensations, callus formation, hair loss, unusual nail changes, and scarring. Some clinicians use handheld microscopes to look for fibers in lesions or beneath unbroken skin.
In dermatology practices that view the condition as delusional infestation, diagnosis often follows a different path. Clinicians may note what’s sometimes called the “matchbox sign,” where patients bring in collected skin samples or fibers for examination. When standard dermatological workups find no infectious cause, and the patient maintains a fixed belief that something is emerging from their skin, a psychiatric diagnosis is typically applied.
Treatment Depends on the Diagnosis
Because the two camps disagree on the cause, they offer very different treatments.
Dermatologists who classify Morgellons as delusional infestation treat it with antipsychotic medications. For decades the standard choice was pimozide, which achieved full remission in roughly half of patients based on a review of over 1,200 case reports. Newer antipsychotic medications with fewer side effects have gradually replaced it. Some patients who present with depression rather than fixed delusions respond to antidepressants instead. Traditional skin treatments like topical steroids and antihistamines have generally not been effective.
Practitioners who treat Morgellons as an infectious disease take an antibiotic-based approach, typically targeting the Borrelia bacteria associated with Lyme disease. At least one published case report documented complete symptom remission after a two-week course of doxycycline, chosen for its established effectiveness against tick-borne Borrelia species. Some patients have more complex infections. Research has found that at least 18% of Morgellons patients also carry other tick-borne organisms, which may require additional treatment.
Where the Name Comes From
The modern use of the term dates to 2001, when biologist Mary Leitao noticed blue and red filaments embedded in her young son’s skin. She borrowed the name from a 1674 letter by English physician Sir Thomas Browne, who had described a similar-sounding condition in children. Leitao founded the Morgellons Research Foundation, a nonprofit that included an online database where people could self-report their symptoms. The foundation helped draw public and scientific attention to the condition before Leitao closed it and withdrew from public life around 2012.
The condition has no reliable prevalence figures. No large-scale epidemiological study has established how many people are affected worldwide, though patient registries and clinical cohorts suggest it is uncommon. Most published research involves relatively small groups of patients, typically ranging from a few dozen to a few hundred, concentrated in North America.